Product Code: ETC6185584 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Morphine remains a critical component in Australia`s pain management and palliative care protocols. The market is regulated and monitored closely due to the opioid crisis. While demand remains strong in hospital settings, strict prescription controls and alternative pain relief therapies may impact long-term growth.
The morphine market in Australia is shaped by its critical role in palliative care, surgical recovery, and chronic pain management. With tighter opioid regulations, there is a growing emphasis on controlled distribution and alternative pain therapies. Pharmaceutical companies are exploring abuse-deterrent formulations and slow-release delivery systems to align with national opioid safety strategies.
The morphine market in Australia is constrained by strict opioid regulations and growing public concern over opioid addiction. Despite being essential for pain management, morphine usage is under heavy scrutiny, limiting its prescription and distribution. Regulatory bodies have introduced measures to curb overuse, which affects market expansion. Healthcare providers are increasingly cautious, and there is a push toward alternative pain therapies, which further pressures the traditional morphine market.
There are steady investment opportunities in Australias regulated morphine market, especially in pharmaceutical manufacturing and supply chain management. As pain management remains a core medical need, investment in slow-release or abuse-deterrent formulations can offer a competitive edge. Moreover, specialized logistics and storage services for controlled substances represent another area of potential growth for investors in pharmaceutical infrastructure.
The Australian government regulates the use of morphine through the TGA, which has implemented strict guidelines for prescribing and distributing opioids. The governments policies aim to prevent opioid misuse and overprescription, following a growing national concern over opioid addiction. The National Pharmaceutical Drug Misuse Strategy and various state-based programs seek to curb misuse and promote the use of alternative pain management therapies. While morphine is still an essential drug for pain management, government policies are pushing for the development and adoption of non-opioid treatments, which may limit the growth of the morphine market in Australia.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Morphine Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Morphine Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Morphine Market - Industry Life Cycle |
3.4 Australia Morphine Market - Porter's Five Forces |
3.5 Australia Morphine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Morphine Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Australia Morphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Morphine Market Trends |
6 Australia Morphine Market, By Types |
6.1 Australia Morphine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Morphine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Morphine Market Revenues & Volume, By Oral Tablets, 2021- 2031F |
6.1.4 Australia Morphine Market Revenues & Volume, By Injection, 2021- 2031F |
6.1.5 Australia Morphine Market Revenues & Volume, By Capsule, 2021- 2031F |
6.1.6 Australia Morphine Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Morphine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia Morphine Market Revenues & Volume, By Anesthesia, 2021- 2031F |
6.2.3 Australia Morphine Market Revenues & Volume, By Cough Suppressant, 2021- 2031F |
6.2.4 Australia Morphine Market Revenues & Volume, By Diarrhea Suppressant, 2021- 2031F |
7 Australia Morphine Market Import-Export Trade Statistics |
7.1 Australia Morphine Market Export to Major Countries |
7.2 Australia Morphine Market Imports from Major Countries |
8 Australia Morphine Market Key Performance Indicators |
9 Australia Morphine Market - Opportunity Assessment |
9.1 Australia Morphine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Morphine Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Australia Morphine Market - Competitive Landscape |
10.1 Australia Morphine Market Revenue Share, By Companies, 2024 |
10.2 Australia Morphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |